Sol-Gel Technologies (SLGL) Net Margin Growth (1y) (2019 - 2026)

Sol-Gel Technologies (SLGL) Net Margin Growth (1y) (2019 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin Growth (1y) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1,491.00
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 1,120.00
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -653.00
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 447.00
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Sol-Gel Technologies 227.58 Mn 217.44 Mn - 259,661.00

Historic Data

Download Data
DateValue
Mar 31, 2026 259,661.00
Dec 31, 2025 1.12 Mn
Sep 30, 2025 -155,656.00
Jun 30, 2025 3,517.00
Dec 31, 2024 -817,577.00
Sep 30, 2024 266,578.00
Jun 30, 2024 -97,516.00
Dec 31, 2023 3.90 Mn
Sep 30, 2023 -268,122.00
Jun 30, 2023 100,124.00
Dec 31, 2022 -5.09 Mn
Sep 30, 2022 0.00
Jun 30, 2022 -86,182.00
Mar 31, 2022 -57,941.00
Dec 31, 2021 0.00
Sep 30, 2021 0.00
Jun 30, 2021 24,162.00
Mar 31, 2021 37,441.00
Dec 31, 2020 -16,423.00
Sep 30, 2020 -15,536.00